The adolescent with asthma: Fostering adherence to optimize therapy

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 6, 2008, Pages 749-753

  Jones, B L ^a,b   Kelly, K J ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; MONTELUKAST; SALMETEROL; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

ADOLESCENT; ADOLESCENT DISEASE; ASTHMA; CHRONIC DISEASE; DOCTOR PATIENT RELATION; DRUG DOSE REGIMEN; HOME MONITORING; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; SELF MEDICATION; SMOKING CESSATION; TREATMENT PLANNING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADOLESCENT BEHAVIOR; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; ATTITUDE TO HEALTH; FEMALE; HUMANS; MALE; NEEDS ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 56549112337     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.189     Document Type: Review

References (47)

1. Hazen, E., Scholzman, S. & Beresin, E. Adolescent psychological development: a review. Pediatr. Rev. 29, 161-168 (2008).
2. Akinbami, L.J. The state of childhood asthma, United States, 1980-2005. Advance Data From Vital and Health Statistics (National Center for Health Statistics, Hyattsville, MD, 2006).
3. Akinbami, L.J. & Schoendorf, K.C. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 110, 315-322 (2002).
4. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, 2007).
5. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J. Allergy Clin. Immunol. 120 (5 suppl.),S94-S138 (2007).
6. Weinstein, A.G. Should patients with persistent severe asthma be monitored for medication adherence? Ann. Allergy Asthma Immunol. 94, 251-257 (2005).
7. Osterberg, L. & Blaschke, T. Adherence to medication. N. Engl. J. Med. 353, 487-497 (2005).
8. Smith, B.A. & Shuchman, M. Problem of nonadherence in chronically ill adolescents: strategies for assessment and intervention. Curr. Opin. Pediatr. 17, 613-618 (2005).
9. McQuaid, E.L., Sheryl, K.J., Klein, R.B. & Fritz, G.K. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J. Pediatr. Psychol. 28, 323-333 (2003).
10. Bender, B. et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and doser CT. Ann. Allergy Asthma Immunol. 85, 416-421 (2000).
11. Butler, K. & Cooper, W.O. Adherence of pediatric asthma patients with oral corticosteroid prescriptions following pediatric emergency department visit or hospitalization. Pediatr. Emerg. Care 20, 730-735 (2004).
12. Adams, R., Weiss, S. & Fuhlbrigge, A. How and by whom care is delivered influences anti-inflammatory use in asthma: results of a national population survey. J. Allergy Clin. Immunol. 112, 445-450 (2003).
13. Fish, L. & Lung, C.L. Adherence to asthma therapy. Ann. Allergy Asthma Immunol. 86, 24-30 (2001).
14. Buston, K.M. & Wood, S.F. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam. Pract. 17, 134-138 (2000).
15. van Es, S.M., le Coq, E.M., Brouwer, A.I., Mesters, I., Nagelkerke, A.F. & Colland, V.T. Adherence-related behavior in adolescents with asthma: results from focus group interviews. J. Asthma 35, 637-646 (1998).
16. Ayala, G.X., Miller, D., Zagami, E., Riddle, C., Willis, S. & King, D. Asthma in middle schools: what students have to say about their asthma. J. Sch. Health 76, 208-214 (2006).
17. Rietveld, S. & Everaerd, W. Perceptions of asthma by adolescents at homes. Chest 117, 434-439 (2000).
18. Mohangoo, A.D., de Koning, H.J., Mangunkusumo, R.T. & Raat, H. Health-related quality of life in adolescents with wheezing attacks. J. Adolesc. Health 41, 464-471 (2007).
19. Munzenberger, P.J., Thomas, R. & Bahraninwala, A. Retention by children of device technique for inhaled asthma drugs between visits. J. Asthma 44, 769-773 (2007).
20. Adams, R.J., Appleton, S., Wilson, D.H. & Ruffin, R.E. Participatory decision making, asthma action plans, and use of asthma medication: a population survey. J. Asthma 42, 673-678 (2005).
21. Coutts, J.A., Gibson, N.A. & Paton, J.Y. Measuring compliance with inhaled medication in asthma. Arch. Dis. Child. 67, 332-333 (1992).
22. Bukstein, D.A., Luskin, A.T. & Berstein, A. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Ann. Allergy Asthma Immunol. 90, 543-549 (2003).
23. Rand, C. et al. Adherence with monteluekast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J. Allergy Clin. Immunol. 119, 916-923 (2007).
24. American Lung Association Asthma Clinical Research Centers, Peters, S.P. et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N. Engl. J. Med. 356, 2027-2039 (2007).
25. Cerasoli, F. Jr. Developing the ideal corticosteroid. Chest 130 (1 suppl.), 54S-64S (2006).
26. de Benedictis, D. & Bush, A. The challenge of asthma in adolescence. Pediatr. Pulmonol. 42, 683-692 (2007).
27. Luskin, A.T. Relationship: the forgotten component. Ann. Allergy Asthma Immunol. 81, 519-521 (1998).
28. Bauman, L.J. et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 110, e6 (2002).
29. Bartlett, S.J., Lukk, P., Butz, A., Lampros-Klein, F. & Rand, C.S. Enhancing medication adherence among inner-city children with asthma: results from pilot studies. J. Asthma 39, 47-54 (2002).
30. Bender, B., Milgrom, H. & Apter, A. Adherence intervention research: what have we learned and what do we do next? J. Allergy Clin. Immunol. 112, 489-494 (2003).
31. Bonner, S., Zimmerman, B.J., Evans, D., Irigoyen, M., Resnick, D. & Mellins, R.B. An individualized intervention to improve asthma management among urban Latino and African-American families. J. Asthma 39, 167-179 (2002).
32. Charles, T., Quinn, D., Weatherall, M., Aldington, S., Beasley, R. & Holt, S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J. Allergy Clin. Immunol. 119, 811-816 (2007).
33. Williams, L.K. et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J. Allergy Clin. Immunol. 120, 1153-1159 (2007).
34. George, M., Freedman, T.G., Norfleet, A.L., Feldman, H.I. & Apter, A.J. Qualitative research-enhanced understanding of patients' beliefs: results of focus groups with low-income, urban, African American adults with asthma. J. Allergy Clin. Immunol. 111, 967-973 (2003).
35. Katon, W., Lozano, P., Russo, J., McCauley, E., Richardson, L. & Bush, T. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared to controls. J. Adolesc. Health 41, 455-463 (2007).
36. Bender, B.G. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am. J. Respir. Crit. Care Med. 173, 953-957 (2006).
37. Kaugars, A.S., Klinnert, M.D. & Bender, B.G. Family influences on pediatric asthma. J. Pediatr. Psychol. 29, 475-491 (2004).
38. Bartlett, S.J., Krishnan, J.A., Riekert, K.A., Butz, A.M., Malveaux, F.J. & Rand, C.S. Maternal depressive symptoms and adherence to therapy in inner-city children with asthma. Pediatrics 113, 229-237 (2004).
39. Strunk, R.C., Mrazek, D.A., Fuhrrmann, G.S. & LaBrecque, J.F. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. A case-controlled study. JAMA 254, 1193-1198 (1985).
40. Abramson, N.W., Wamboldt, F.S., Mansell, A.L., Carter, R., Federico, M.J. & Wamboldt, M.Z. Frequency and correlates of overweight status in adolescent asthma. J. Asthma 45, 135-139 (2008).
41. Chinn, S. Obesity and asthma. Paediatr. Respir. Rev. 7, 223-228 (2006).
42. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911-919 (2005).
43. Jones, S.E., Merkle, S., Wheeler, L., Mannino, D.M. & Crossett, L. Tobacco and other drug use among high school students with asthma. J. Adolesc. Health 39, 291-294 (2006).
44. Apter, A.J., Tor, M. & Feldman, H.I. Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers. Ann. Allergy Asthma Immunol. 86, 421-424 (2001).
45. Julius, S.M., Sherman, J.M. & Hendeles, L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 121, 871-876 (2002).
46. Eney, R.D. & Goldstein, E.O. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum salivary levels. Pediatrics 57, 513-517 (1976).
47. Onyirimba, F. et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann. Allergy Asthma Immunol. 90, 411-415 (2003).